God I thought you'd reply with chapter and verse of the relevant law and sure enough. The law on this is not an absolute requirement it's a judgement based on all the circumstances. All of them.
A minor setback happens all the time in clinical testing situations and not all of them are reported in real time. The entire clinical testing process is confidential and it takes time to process the implications of any setback and work out if it's substantial or not. If it can be resolved it won't be substantial.
The point of the continuous disclosure obligation is to manage possible leaks so nobody gains an unfair advantage and the market gets informed all together.
If the setback is not material, or insignificant it may try to solve the problem and not even report it at all. This happens in clinical trials all the time. Otherwise the market would be constantly jumping about results it cannot even begin to possibly process while adjustments are being made. Right? They go on all the time and you and I are not privy to them. No need to get excited.
You always have to look at the purpose when you're reading legislation, and not read it restrictively or too widely.
You're being very extreme in your judgements here because again, you're looking for someone to blame. Instead of stepping back and understanding risk and how it applies here.
Please go back and read my comments more carefully. I think people are being very patient over this because it's a very tough situation. I know how you feel but the accusations you're making are sometimes unwise.
AHZ Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
(20min delay)